PME speaks to Iskra Reic, the company’s head of European countries and Canada
Astra Zeneca’s mind of European countries and Canada Iskra Reic
Iskra Reic ended up being appointed executive vice president of Europe for AstraZeneca in April 2017 as well as in a reshuffle at the start of 2019, Canada had been put into that profile.
Nevertheless, it absolutely was an additional huge and country that is snowy she actually cut her administration teeth – Russia.
Trained as a physician of dental surgery during the healthcare University of Zagreb inside her indigenous Croatia, Reic joined up with AstraZeneca in 2001 and quickly ascended through the organization, heading up Specialty Care in Central and Eastern Europe, center East and Africa before landing the manager that is general in Russia in 2014.
Under her leadership, AstraZeneca achieved a respected share in its three primary treatment areas and became a premier three prescription medication pharma business in Russia.
Reic’s obligations had been expanded in 2016 to pay for both Russia therefore the Eurasia region, where she led a team that is 1,500-strong an ‘emerging market’ region. Such areas can offer growth that is rapid but can additionally show to be often volatile and unpredictable.
Reic stated her amount of time in Russia in specific has taught her the effectiveness of tenacity, freedom and a can-do spirit – maybe perhaps perhaps not just like a frontrunner, however for the entire group working in an industry that will alter instantly.
“Russia is a market that is exciting work with, you need to be actually devoted to it getting through the bad times.
“We brought a whole lot of new medications to clients here, which involved work that is intensive educating health care specialists therefore the federal government in regards to the value of innovation in pharma.”